Diisopropylethylamine → 2-cyclopropyl-8-methyl-3-((1S)-1-(9-(tetrahydro-2H-Pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one

HRID 1502503

반응식

HRID 1502503 반응식
N[C@H](C1N(C2CC2)C(=O)C2C(C=1)=CC=CC=2C)C.ClC1N=CN=C2C=1N=CN2C1CCCCO1.CCN(C(C)C)C(C)C.[CH:44]1([N:47]2[C:56]([C@@H:57]([NH:59][C:60]3[N:68]=[CH:67][N:66]=[C:65]4[C:61]=3[N:62]=[CH:63][N:64]4[CH:69]3[CH2:74][CH2:73][CH2:72][CH2:71][O:70]3)[CH3:58])=[CH:55][C:54]3[C:49](=[C:50]([CH3:75])[CH:51]=[CH:52][CH:53]=3)[C:48]2=[O:76])[CH2:46][CH2:45]1>CCCCO>[N:68]1[C:60]([NH:59][C@H:57]([C:56]2[N:47]([CH:44]3[CH2:46][CH2:45]3)[C:48](=[O:76])[C:49]3[C:54]([CH:55]=2)=[CH:53][CH:52]=[CH:51][C:50]=3[CH3:75])[CH3:58])=[C:61]2[C:65]([NH:64][CH:63]=[N:62]2)=[N:66][CH:67]=1.[CH:44]1([N:47]2[C:56]([C@@H:57]([NH:59][C:60]3[N:68]=[CH:67][N:66]=[C:65]4[C:61]=3[N:62]=[CH:63][N:64]4[CH:69]3[CH2:74][CH2:73][CH2:72][CH2:71][O:70]3)[CH3:58])=[CH:55][C:54]3[C:49](=[C:50]([CH3:75])[CH:51]=[CH:52][CH:53]=3)[C:48]2=[O:76])[CH2:45][CH2:46]1

참가 물질

7

실험 절차

(S)-3-(1-Aminoethyl)-2-cyclopropyl-8-methylisoquinolin-1(2H)-one (242 mg, 1 mmol) (compound 5003), 6-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (344 mg, 1.44 mmol) and DIPEA (279 mg, 2.16 mmol) were dissolved in n-BuOH (20 mL), and the resulting mixture was stirred at reflux for 16 h. The reaction mixture was concentrated in vacuo and the residue was purified by flash column chromatography on silica gel (eluting with 30% to 50% Hex/EA) to afford the desired product, 2-cyclopropyl-8-methyl-3-((1S)-1-(9-(tetrahydro-2H-Pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one (compound 5004) (288 mg, 65% yield) as a white solid.

후처리

  1. temperatureat reflux for 16 h
  2. concentrationThe reaction mixture was concentrated in vacuo
  3. customthe residue was purified by flash column chromatography on silica gel (eluting with 30% to 50% Hex/EA)

출처 및 근거

ORD 기록
ord-086cba3de83243bdac7df65a1d5005d7
출처 데이터셋
uspto-grants-2015_12
특허 번호
US09206182B2

연결된 노트

불러오는 중…